HealthEquity (NASDAQ:HQY) VP Ashley Dreier sold 36,000 shares of the company’s stock in a transaction dated Monday, May 14th. The shares were sold at an average price of $70.94, for a total transaction of $2,553,840.00. Following the completion of the sale, the vice president now directly owns 49,939 shares of the company’s stock, valued at approximately $3,542,672.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Ashley Dreier also recently made the following trade(s):

  • On Wednesday, May 2nd, Ashley Dreier sold 3,000 shares of HealthEquity stock. The shares were sold at an average price of $67.00, for a total transaction of $201,000.00.
  • On Monday, April 30th, Ashley Dreier sold 16,250 shares of HealthEquity stock. The shares were sold at an average price of $67.00, for a total transaction of $1,088,750.00.
  • On Thursday, March 22nd, Ashley Dreier sold 71,157 shares of HealthEquity stock. The shares were sold at an average price of $65.48, for a total transaction of $4,659,360.36.

Shares of HealthEquity opened at $72.24 on Friday, Marketbeat reports. The stock has a market cap of $4.34 billion, a price-to-earnings ratio of 133.78, a P/E/G ratio of 2.85 and a beta of 1.39. HealthEquity has a 1-year low of $71.00 and a 1-year high of $71.60.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Monday, March 19th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.06. The business had revenue of $60.44 million for the quarter, compared to analysts’ expectations of $58.46 million. HealthEquity had a net margin of 20.64% and a return on equity of 13.47%. equities analysts forecast that HealthEquity will post 0.77 EPS for the current year.

Several research analysts have weighed in on the stock. Zacks Investment Research lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, May 12th. Oppenheimer increased their target price on shares of HealthEquity from $58.00 to $68.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 20th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $65.00 target price on shares of HealthEquity in a research note on Friday, March 23rd. Robert W. Baird increased their target price on shares of HealthEquity from $49.00 to $61.00 and gave the stock a “neutral” rating in a research note on Tuesday, March 20th. They noted that the move was a valuation call. Finally, JPMorgan Chase assumed coverage on shares of HealthEquity in a research note on Tuesday, April 24th. They set an “overweight” rating and a $69.00 target price for the company. Two equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. HealthEquity currently has an average rating of “Buy” and an average target price of $68.30.

Institutional investors and hedge funds have recently modified their holdings of the company. Global X Management Co. LLC lifted its position in shares of HealthEquity by 180.6% during the fourth quarter. Global X Management Co. LLC now owns 36,601 shares of the company’s stock worth $1,708,000 after purchasing an additional 23,556 shares in the last quarter. Signition LP acquired a new stake in shares of HealthEquity during the fourth quarter worth about $348,000. California Public Employees Retirement System lifted its position in shares of HealthEquity by 7.5% during the fourth quarter. California Public Employees Retirement System now owns 103,028 shares of the company’s stock worth $4,807,000 after purchasing an additional 7,169 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of HealthEquity by 12.2% during the third quarter. Dimensional Fund Advisors LP now owns 531,288 shares of the company’s stock worth $26,872,000 after purchasing an additional 57,855 shares in the last quarter. Finally, Rock Springs Capital Management LP lifted its position in shares of HealthEquity by 18.2% during the fourth quarter. Rock Springs Capital Management LP now owns 195,000 shares of the company’s stock worth $9,099,000 after purchasing an additional 30,000 shares in the last quarter. 98.16% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.